Literature DB >> 14160221

SEROLOGICAL DIAGNOSIS OF TUBERCULOSIS.

R GER.   

Abstract

Keywords:  COMPLEMENT FIXATION TESTS

Mesh：

Year:  1964        PMID： 14160221      PMCID： PMC1816318     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  [CIRCULATING ANTIBODIES DEMONSTRATED BY PASSIVE INDIRECT HEMAGGLUTINATION BY MEANS OF TUBERCULIN HAPTEN (PPD) DEVELOPING IN HUMAN TUBERCULOSIS].

Authors:  G FAVEZ
Journal:  Schweiz Med Wochenschr       Date:  1964-02-01

2.  MODIFICATIONS OF THE AGAR DOUBLE DIFFUSION PRECIPITIN TEST FOR TUBERCULOSIS.

Authors:  W MORTON; H J DODGE
Journal:  Am Rev Respir Dis       Date:  1963-08

3.  Comparison of gel precipitin and sensitized erythrocyte techniques for the detection of antibody in the serum of tuberculous and non-tuberculous patients.

Authors:  J R THURSTON; W STEENKEN
Journal:  Am Rev Respir Dis       Date:  1960-05

4.  [Experimental tuberculosis and the existence of 3 different antibodies: antipolysaccharide, antiprotein and antiphosphatide].

Authors:  Y TAKAHASHI; T ONODERA
Journal:  C R Seances Soc Biol Fil       Date:  1960

5.  [Human pulmonary tuberculosis an three different antibodies: antipolyoside, antiprotein and antiphosphatide].

Authors:  Y TAKAHASHI; K MOCHIZUKI; Y NAGAYAMA
Journal:  C R Seances Soc Biol Fil       Date:  1960

6.  Serological studies of mycobacteria by means of diffusion-in-gel techniques. V. A comparison between the plate and the tube techniques for the demonstration of precipitins in sera from tuberculous patients.

Authors:  A LIND
Journal:  Int Arch Allergy Appl Immunol       Date:  1961

7.  The detection of antibodies in the serum of tuberculous patients by an agar double-diffusion precipitation technique.

Authors:  R C PARLETT; G P YOUMANS; C REHR; W LESTER
Journal:  Am Rev Tuberc       Date:  1958-03

8.  The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera.

Authors:  S V BOYDEN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.